5 insiders reported 10 Form 4 transactions for Nautilus Biotechnology, Inc. (NAUT) over the past 18 months (most recent 2026-03-04). Recent activity: Patel Sujal M (CEO, President, and Secretary) Buy 25,000 shares, Suzuki Kentaro (Chief Marketing Officer) Buy 4,000 shares, Patel Sujal M (CEO, President, and Secretary) Buy 116,500 shares, Patel Sujal M (CEO, President, and Secretary) Buy 83,500 shares, Murphy Matthew B. (General Counsel) Buy 20,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-04 | Patel Sujal M | CEO, President, and Secretary | Buy | 25,000 | $65,250 |
| 2025-11-10 | Suzuki Kentaro | Chief Marketing Officer | Buy | 4,000 | $5,960 |
| 2025-09-09 | Patel Sujal M | CEO, President, and Secretary | Buy | 116,500 | $78,055 |
| 2025-09-09 | Patel Sujal M | CEO, President, and Secretary | Buy | 83,500 | $56,780 |
| 2025-09-05 | Murphy Matthew B. | General Counsel | Buy | 20,000 | $12,800 |
| 2025-06-02 | Mowry Anna | CFO and Treasurer | Buy | 15,000 | $11,550 |
| 2025-05-12 | Mallick Parag | Chief Scientist | Buy | 12,000 | $8,760 |
| 2025-05-12 | Mallick Parag | Chief Scientist | Buy | 1,500 | $1,095 |
| 2025-03-21 | Patel Sujal M | CEO, President, and Secretary | Buy | 53,300 | $52,767 |
| 2025-03-21 | Patel Sujal M | CEO, President, and Secretary | Buy | 23,933 | $23,933 |
Source: SEC Form 4 filings · as of 2026-03-04